|Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines|
M Najlah, A Kadam, KW Wan, W Ahmed, KMG Taylor, AMA Elhissi
International journal of pharmaceutics 506 (1-2), 102-109, 2016
|Stability of parenteral nanoemulsions loaded with paclitaxel: the influence of lipid phase composition, drug concentration and storage temperature|
AN Kadam, M Najlah, KW Wan, W Ahmed, SJ Crean, DA Phoenix, ...
Pharmaceutical development and technology 19 (8), 999-1004, 2014
|Viral nanoparticles decorated with novel EGFL7 ligands enable intravital imaging of tumor neovasculature|
CF Cho, L Yu, TK Nsiama, AN Kadam, A Raturi, S Shukla, GA Amadei, ...
Nanoscale 9 (33), 12096-12109, 2017
|EGFL7 inhibits tumor angiogenesis via its Emilin-like domain|
|Paclitaxel loaded lipid nanoemulsions for the treatment of brain tumour|
M Najlah, A Kadam, KW Wan, W Ahmed, A Elhissi
|A novel EGFL7-derived peptide, E7C13, is a potent anti-tumor agent that inhibits angiogenesis in a beta 1 integrin-and thrombospondin-dependent manner|
CF Cho, LA Fung, T Nsiama, L Yu, A Kadam, DF Quail, ...
Cancer Research 74 (19 Supplement), 4812-4812, 2014
|Nanoemulsion formulations for brain tumour therapy|
University of Central Lancashire, 2013